Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Immunogenicity of a non-class I MHC expressing murine tumor transfected with the influenza virus hemagglutinin or murine interleukin-2 genes

Identifieur interne : 002051 ( Main/Exploration ); précédent : 002050; suivant : 002052

Immunogenicity of a non-class I MHC expressing murine tumor transfected with the influenza virus hemagglutinin or murine interleukin-2 genes

Auteurs : Toshiyuki Itaya [États-Unis] ; Eric Fearon [États-Unis] ; Troy Fiesinger [États-Unis] ; Barbara Hunt [États-Unis] ; Bert Vogelstein [États-Unis] ; Philip Frost [États-Unis]

Source :

RBID : ISTEX:5F7004DC620E12640BA9229D8FFE0938FB8B9614

English descriptors

Abstract

Summary: The transfection of murine SP1 tumor cells with the hemagglutinin (HA) gene of influenza virus results, after fluorescent-activated cell sorting (FACS), in the selection of high-HA-expressing cell lines called H4A and H4B. Both lines fail to grow in syngeneic animals at doses that result in 100% tumor take of non-transfected tumor cells. Both grow in immunosuppressed mice. SP1 and H4A or H4B cells express few class I major histocompatibility complex (MHC) antigens but do express class II IAk antigens. H4A or H4B cells engender a cytotoxic T lymphocyte (CTL) response but cannot protect against a challenge with SP1 cells. This CTL response is inhibited by anti-CD4 but not anti-CD8 antibodies. Using FACS, we were able to select a population (called H5AK5) with high class-I MHC antigen expression. Like H4A and H4B, H5AK5 cells fail to grow in syngeneic animals but do grow in immunosuppressed mice. However, unlike H4A or H4B, H5AK5 can induce protection against a challenge with 1 × 105 SP1 cells. These studies indicate that the immunogenicity ofHA-transfected SP1 cells may correlate with the cell-surface expression of class II MHC antigens. However, HA-expressing SP1 cells seem able to induce a protective response against a parent SP1 cell challenge only if they also express class I MHC antigens. This view is supported by the observations that SP1 cells expressing murine interleukin-2 do not express class I MHC antigens, fail to grow in syngeneic animals, do grow in immunosuppressed mice but do not protect against a challenge with parental SP1 cells.

Url:
DOI: 10.1007/BF01744947


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Immunogenicity of a non-class I MHC expressing murine tumor transfected with the influenza virus hemagglutinin or murine interleukin-2 genes</title>
<author>
<name sortKey="Itaya, Toshiyuki" sort="Itaya, Toshiyuki" uniqKey="Itaya T" first="Toshiyuki" last="Itaya">Toshiyuki Itaya</name>
</author>
<author>
<name sortKey="Fearon, Eric" sort="Fearon, Eric" uniqKey="Fearon E" first="Eric" last="Fearon">Eric Fearon</name>
</author>
<author>
<name sortKey="Fiesinger, Troy" sort="Fiesinger, Troy" uniqKey="Fiesinger T" first="Troy" last="Fiesinger">Troy Fiesinger</name>
</author>
<author>
<name sortKey="Hunt, Barbara" sort="Hunt, Barbara" uniqKey="Hunt B" first="Barbara" last="Hunt">Barbara Hunt</name>
</author>
<author>
<name sortKey="Vogelstein, Bert" sort="Vogelstein, Bert" uniqKey="Vogelstein B" first="Bert" last="Vogelstein">Bert Vogelstein</name>
</author>
<author>
<name sortKey="Frost, Philip" sort="Frost, Philip" uniqKey="Frost P" first="Philip" last="Frost">Philip Frost</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5F7004DC620E12640BA9229D8FFE0938FB8B9614</idno>
<date when="1991" year="1991">1991</date>
<idno type="doi">10.1007/BF01744947</idno>
<idno type="url">https://api.istex.fr/ark:/67375/1BB-K9T2DQ19-R/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000C25</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000C25</idno>
<idno type="wicri:Area/Istex/Curation">000C25</idno>
<idno type="wicri:Area/Istex/Checkpoint">000D93</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000D93</idno>
<idno type="wicri:doubleKey">0340-7004:1991:Itaya T:immunogenicity:of:a</idno>
<idno type="wicri:Area/Main/Merge">002150</idno>
<idno type="wicri:Area/Main/Curation">002051</idno>
<idno type="wicri:Area/Main/Exploration">002051</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Immunogenicity of a non-class I MHC expressing murine tumor transfected with the influenza virus hemagglutinin or murine interleukin-2 genes</title>
<author>
<name sortKey="Itaya, Toshiyuki" sort="Itaya, Toshiyuki" uniqKey="Itaya T" first="Toshiyuki" last="Itaya">Toshiyuki Itaya</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Cell Biology, University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 173, 77 030, Houston, Texas</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Fearon, Eric" sort="Fearon, Eric" uniqKey="Fearon E" first="Eric" last="Fearon">Eric Fearon</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Johns Hopkins University Oncology Center, 21 231, Baltimore, Maryland</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Fiesinger, Troy" sort="Fiesinger, Troy" uniqKey="Fiesinger T" first="Troy" last="Fiesinger">Troy Fiesinger</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Cell Biology, University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 173, 77 030, Houston, Texas</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hunt, Barbara" sort="Hunt, Barbara" uniqKey="Hunt B" first="Barbara" last="Hunt">Barbara Hunt</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Cell Biology, University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 173, 77 030, Houston, Texas</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Vogelstein, Bert" sort="Vogelstein, Bert" uniqKey="Vogelstein B" first="Bert" last="Vogelstein">Bert Vogelstein</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Johns Hopkins University Oncology Center, 21 231, Baltimore, Maryland</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Frost, Philip" sort="Frost, Philip" uniqKey="Frost P" first="Philip" last="Frost">Philip Frost</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Cell Biology, University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 173, 77 030, Houston, Texas</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 77 030, Houston, Texas</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Cancer Immunology, Immunotherapy</title>
<title level="j" type="abbrev">Cancer Immunol Immunother</title>
<idno type="ISSN">0340-7004</idno>
<idno type="eISSN">1432-0851</idno>
<imprint>
<publisher>Springer-Verlag</publisher>
<pubPlace>Berlin/Heidelberg</pubPlace>
<date type="published" when="1991-07-01">1991-07-01</date>
<biblScope unit="volume">33</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="267">267</biblScope>
<biblScope unit="page" to="273">273</biblScope>
</imprint>
<idno type="ISSN">0340-7004</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0340-7004</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Hemagglutinin</term>
<term>Immunogenicity</term>
<term>Major histocompatibility complex</term>
<term>Transfected genes</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Antigen</term>
<term>Antigen expression</term>
<term>Bovine vector</term>
<term>Cell cytotoxicity</term>
<term>Cell line</term>
<term>Cell lines</term>
<term>Cells fall</term>
<term>Cells secreting</term>
<term>Cells transfected</term>
<term>Challenge dose</term>
<term>Clone</term>
<term>Control cells</term>
<term>Different doses</term>
<term>Dos</term>
<term>Effector lymphocytes</term>
<term>Facs</term>
<term>High levels</term>
<term>Histocompatibility</term>
<term>Ifny</term>
<term>Immune response</term>
<term>Immunization</term>
<term>Immunogenic</term>
<term>Immunogenic variants</term>
<term>Immunogenicity</term>
<term>Immunol</term>
<term>Immunosuppressed</term>
<term>Immunosuppressed mice</term>
<term>Influenza</term>
<term>Influenza virus hemagglutinin</term>
<term>Little class</term>
<term>Major histocompatibility</term>
<term>Metallothionein promoter</term>
<term>Mouse</term>
<term>Murine</term>
<term>Murine colon tumor</term>
<term>Natl cancer inst</term>
<term>Next page</term>
<term>Normal mice</term>
<term>Nude mice</term>
<term>Parent cells</term>
<term>Protective effect</term>
<term>Psv2neo</term>
<term>Same medium</term>
<term>Spleen cells</term>
<term>Spontaneous murine carcinoma</term>
<term>Surface class</term>
<term>Syngeneic</term>
<term>Syngeneic animals</term>
<term>Transfected</term>
<term>Transfected cells</term>
<term>Transfection</term>
<term>Tumor cells</term>
<term>Tumor growth</term>
<term>Viable cells</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Summary: The transfection of murine SP1 tumor cells with the hemagglutinin (HA) gene of influenza virus results, after fluorescent-activated cell sorting (FACS), in the selection of high-HA-expressing cell lines called H4A and H4B. Both lines fail to grow in syngeneic animals at doses that result in 100% tumor take of non-transfected tumor cells. Both grow in immunosuppressed mice. SP1 and H4A or H4B cells express few class I major histocompatibility complex (MHC) antigens but do express class II IAk antigens. H4A or H4B cells engender a cytotoxic T lymphocyte (CTL) response but cannot protect against a challenge with SP1 cells. This CTL response is inhibited by anti-CD4 but not anti-CD8 antibodies. Using FACS, we were able to select a population (called H5AK5) with high class-I MHC antigen expression. Like H4A and H4B, H5AK5 cells fail to grow in syngeneic animals but do grow in immunosuppressed mice. However, unlike H4A or H4B, H5AK5 can induce protection against a challenge with 1 × 105 SP1 cells. These studies indicate that the immunogenicity ofHA-transfected SP1 cells may correlate with the cell-surface expression of class II MHC antigens. However, HA-expressing SP1 cells seem able to induce a protective response against a parent SP1 cell challenge only if they also express class I MHC antigens. This view is supported by the observations that SP1 cells expressing murine interleukin-2 do not express class I MHC antigens, fail to grow in syngeneic animals, do grow in immunosuppressed mice but do not protect against a challenge with parental SP1 cells.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Maryland</li>
<li>Texas</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Texas">
<name sortKey="Itaya, Toshiyuki" sort="Itaya, Toshiyuki" uniqKey="Itaya T" first="Toshiyuki" last="Itaya">Toshiyuki Itaya</name>
</region>
<name sortKey="Fearon, Eric" sort="Fearon, Eric" uniqKey="Fearon E" first="Eric" last="Fearon">Eric Fearon</name>
<name sortKey="Fiesinger, Troy" sort="Fiesinger, Troy" uniqKey="Fiesinger T" first="Troy" last="Fiesinger">Troy Fiesinger</name>
<name sortKey="Frost, Philip" sort="Frost, Philip" uniqKey="Frost P" first="Philip" last="Frost">Philip Frost</name>
<name sortKey="Frost, Philip" sort="Frost, Philip" uniqKey="Frost P" first="Philip" last="Frost">Philip Frost</name>
<name sortKey="Hunt, Barbara" sort="Hunt, Barbara" uniqKey="Hunt B" first="Barbara" last="Hunt">Barbara Hunt</name>
<name sortKey="Vogelstein, Bert" sort="Vogelstein, Bert" uniqKey="Vogelstein B" first="Bert" last="Vogelstein">Bert Vogelstein</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002051 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002051 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:5F7004DC620E12640BA9229D8FFE0938FB8B9614
   |texte=   Immunogenicity of a non-class I MHC expressing murine tumor transfected with the influenza virus hemagglutinin or murine interleukin-2 genes
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021